Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2661
Summary
- I currently serve as an Assistant Professor of Medicine and Public Health at the University of Texas Southwestern Medical Center. I practice and conduct research as a hemoncologist and epidemiologist focusing on myeloma/monoclonal gammopathies, cancer epidemiology, and general medicine/public health.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
- Columbia University Mailman School of Public HealthMS, Executive Program in Epidemiology, 2017 - 2019
- Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2017
- University of Michigan Medical SchoolClass of 2014
- Harvard T. H. Chan School of Public HealthMPH, Quantitative Methods, 2012 - 2013
- University of OklahomaBA, Mathematics, Psychology, 2003 - 2007
Certifications & Licensure
- MA State Medical License 2017 - 2025
- TX State Medical License 2022 - 2025
- OH State Medical License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 13 citationsOverall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosis.Thita Chiasakul, Robert A. Redd, Rushad Patell, Adeel M Khan, Ellen P. McCarthy
Journal of Thrombosis and Haemostasis. 2021-09-07 - 24 citationsCases of ROS1 -rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M Khan, Deepa Rangachari
Precision Cancer Medicine. 2020-06-15 - 5 citationsSurvival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort st...Adeel M Khan, Thita Chiasakul, Robert Redd, Rushad Patell, Ellen P McCarthy
Plos Medicine. 2022-05-01
Journal Articles
- A Cancer by Any Other NameKhan AM, The Oncologist, 10/9/2021
Press Mentions
- Cancer-Causing Chemical Was Found in These Diabetes Medications: Merck Says They Can Fix ItJanuary 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: